These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas. Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368 [TBL] [Abstract][Full Text] [Related]
25. Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Hopman AH; Poddighe PJ; Smeets AW; Moesker O; Beck JL; Vooijs GP; Ramaekers FC Am J Pathol; 1989 Dec; 135(6):1105-17. PubMed ID: 2688431 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours. Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481 [TBL] [Abstract][Full Text] [Related]
27. Flow-cytometric quantification in human gliomas of alpha satellite DNA sequences specific for chromosome 7 using fluorescence in situ hybridization. Kwak T; Nishizaki T; Ito H; Kimura Y; Murakami T; Sasaki K Cytometry; 1994 Sep; 17(1):26-32. PubMed ID: 8001457 [TBL] [Abstract][Full Text] [Related]
28. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Kovacs G; Frisch S Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484 [TBL] [Abstract][Full Text] [Related]
29. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. Poddighe PJ; Bringuier PP; Vallinga M; Schalken JA; Ramaekers FC; Hopman AH J Pathol; 1996 Jun; 179(2):169-76. PubMed ID: 8758209 [TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602 [TBL] [Abstract][Full Text] [Related]
31. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792 [TBL] [Abstract][Full Text] [Related]
32. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization. Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305 [TBL] [Abstract][Full Text] [Related]
34. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease. Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293 [TBL] [Abstract][Full Text] [Related]
35. Numerical aberrations of chromosomes 8, 9, 11, and 17 in squamous cell carcinoma of the pharynx and larynx: a fluorescence in situ hybridization and DNA flow cytometric analysis of 50 cases. Hardisson D; Alvarez-Marcos C; Salas-Bustamante A; Alonso-Guervós M; Sastre N; Sampedro A Oral Oncol; 2004 Apr; 40(4):409-17. PubMed ID: 14969820 [TBL] [Abstract][Full Text] [Related]